Sarcoma

Showing NaN - NaN of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Molecular Testing for MD Anderson Cancer Center Personalized

Recruiting
  • Glioma
  • +4 more
  • Biospecimen Collection
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Gastric Cancer, Renal Cell Carcinoma, Melanoma Trial in United States (HFB200301)

Recruiting
  • Gastric Cancer
  • +8 more
  • Scottsdale, Arizona
  • +9 more
Dec 22, 2022

Sarcoma Trial in Houston (Autologous HER2-specific T cells, Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Sarcoma
  • Autologous HER2-specific T cells
  • +3 more
  • Houston, Texas
  • +1 more
Nov 21, 2022

Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)

Completed
  • Prostate Cancer
  • +4 more
  • NY-ESO-1 Plasmid DNA Cancer Vaccine
  • New York, New York
  • +1 more
Oct 3, 2022

Malignant Digestive System Tumor, Metastatic Head and Neck Carcinoma, Metastatic Kidney Carcinoma Trial in Houston (procedure,

Recruiting
  • Malignant Digestive System Neoplasm
  • +12 more
  • Computed Tomography
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
Jun 21, 2022

Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma Trial in United States (CBX-12)

Recruiting
  • Solid Tumor, Adult
  • +11 more
  • New Haven, Connecticut
  • +3 more
May 9, 2022

SARCOMA Trial in New York, Houston (NKTR-214, Nivolumab)

Active, not recruiting
  • SARCOMA
  • New York, New York
  • +1 more
May 6, 2022

Sarcoma Trial in Houston (Best Practice, Informational Intervention, Questionnaire Administration)

Recruiting
  • Sarcoma
  • Best Practice
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 18, 2022

Sarcoma, HER-2 Protein Overexpression Trial in Houston (cells, Pembrolizumab Injectable Product, Nivolumab Injectable Product)

Recruiting
  • Sarcoma
  • HER-2 Protein Overexpression
  • cells
  • +3 more
  • Houston, Texas
    Texas Children's Hospital
Dec 8, 2021

Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,

Completed
  • Advanced Solid Tumors
  • +8 more
  • Modified FOLFOX6
  • +3 more
  • Duarte, California
  • +11 more
Feb 3, 2021

Sarcoma Trial in Worldwide (RG1507)

Terminated
  • Sarcoma
  • Duarte, California
  • +40 more
Jan 14, 2021

Sarcoma Trial in Houston (Ra-223 Dichloride)

Completed
  • Sarcoma
  • Ra-223 Dichloride
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 13, 2021

Detecting Anal and Genital Human Papillomavirus Infection and

Completed
  • Aids-related Malignancies
  • +3 more
  • polymerase chain reaction
  • +3 more
  • La Jolla, California
  • +9 more
Aug 7, 2020

Sarcoma, Melanoma, NSCLC Trial in United States (CMB305, G100, Metronomic CPA)

Terminated
  • Sarcoma
  • +3 more
  • CMB305
  • +2 more
  • Santa Monica, California
  • +7 more
Jun 29, 2020

Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

Completed
  • Hematological Neoplasms
  • +19 more
  • Scottsdale, Arizona
  • +9 more
May 11, 2020

Synovial Sarcoma, Cancer, Soft Tissue Sarcoma Trial in Canada, United States (LV305, G305, LV305-matching )

Terminated
  • Synovial Sarcoma
  • +4 more
  • LV305
  • +3 more
  • Scottsdale, Arizona
  • +28 more
Apr 3, 2020

Sarcoma Trial in United States (Gemcitabine and Pazopanib, Gemcitabine and Docetaxel)

Completed
  • Sarcoma
  • Gemcitabine and Pazopanib
  • Gemcitabine and Docetaxel
  • Tucson, Arizona
  • +7 more
Mar 23, 2020

Colorectal Cancer, Triple Negative Breast Cancer, Pancreatic Cancer Trial in Denver, Miami, Houston (Toca 511, Toca FC)

Terminated
  • Colorectal Cancer
  • +11 more
  • Toca 511
  • Toca FC
  • Denver, Colorado
  • +2 more
Feb 5, 2020

Sarcoma Trial in Worldwide (biological, drug, procedure, radiation)

Completed
  • Sarcoma
  • dactinomycin
  • +9 more
  • Birmingham, Alabama
  • +165 more
Jan 15, 2020

Advanced Cancers, Sarcoma Trial in Houston (Hyperthermic Peritoneal Perfusion (HIPEC), Cisplatin)

Completed
  • Advanced Cancers
  • Sarcoma
  • Hyperthermic Peritoneal Perfusion (HIPEC)
  • Cisplatin
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 8, 2020